Renovaro is expanding the ongoing strategic collaboration with Nebul to advance the early detection of cancer and other diseases. The partnership aims to leverage Renovaro’s deep learning and ML programs with Nebul’s high-performance computing built on the latest platform to accelerate biomarker discovery and next-generation diagnostics.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RENB:
- Renovaro BioSciences, BioSymetrics close merger transaction
- China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz
- Renovaro says Predictive Oncology terminates merger transaction
- Renovaro BioSciences provides update to agreement with Predictive Oncology
- Renovaro says Predictive Oncology terminated merger agreement
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue